{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T04:58:16Z","timestamp":1790485096064,"version":"4.1.0"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,12,27]],"date-time":"2019-12-27T00:00:00Z","timestamp":1577404800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,12,27]],"date-time":"2019-12-27T00:00:00Z","timestamp":1577404800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Yeast cell wall particles isolated from<jats:italic>Saccharomyces cerevisiae<\/jats:italic>(<jats:italic>sc<\/jats:italic>YCWPs) have a rich constitution of \u03b2-glucan derived from the cell wall. After removing intracellular contents, \u03b2-glucan molecules are readily recognized by dectin-1 receptors, present on the cytoplasmic membrane surface of the mononuclear phagocytic cells and internalized.<jats:italic>Leishmania<\/jats:italic>spp. are obligate intracellular parasites; macrophages are its primary host cells. An experimental murine model of visceral leishmaniasis caused by<jats:italic>L. infantum<\/jats:italic>was used to evaluate the antileishmanial activity of oral administration of these particles. A low-water soluble thiophene previously studied<jats:italic>in vitro<\/jats:italic>against<jats:italic>L. infantum<\/jats:italic>was entrapped into<jats:italic>sc<\/jats:italic>YCWPs to direct it into the host cell, in order to circumvent the typical pharmacokinetic problems of water-insoluble compounds. We found that<jats:italic>sc<\/jats:italic>YCWPs\u2009+\u2009T6 reduced the parasitic burden in the liver and spleen. There was an increase in IFN-\u03b3 levels related to nitric oxide production, explaining the reduction of the<jats:italic>L. infantum<\/jats:italic>burden in the tissue. Histological analysis did not show signals of tissue inflammation and biochemical analysis from plasma did not indicate signals of cytotoxicity after<jats:italic>sc<\/jats:italic>YCWPs\u2009+\u2009T6 treatment. These findings suggested that<jats:italic>sc<\/jats:italic>YCWPs\u2009+\u2009T6 administered through oral route reduced the parasitic burden without causing toxic effects, satisfying requirements for development of new strategies to treat leishmaniasis.<\/jats:p>","DOI":"10.1038\/s41598-019-56647-w","type":"journal-article","created":{"date-parts":[[2019,12,27]],"date-time":"2019-12-27T11:02:42Z","timestamp":1577444562000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Oral treatment with T6-loaded yeast cell wall particles reduces the parasitemia in murine visceral leishmaniasis model"],"prefix":"10.1038","volume":"9","author":[{"given":"D\u00e9bora B.","family":"Scariot","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9lito","family":"Volpato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2824-0618","authenticated-orcid":false,"given":"Nilma S.","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2579-0048","authenticated-orcid":false,"given":"Danielle","family":"Lazarin-Bid\u00f3ia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Borges","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria do C\u00e9u","family":"Sousa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernanda A.","family":"Rosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrey P.","family":"Jacomini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sueli O.","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T\u00e2nia","family":"Ueda-Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adley F.","family":"Rubira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celso V.","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,12,27]]},"reference":[{"key":"56647_CR1","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1001\/jama.2017.7467","volume":"318","author":"N Jain","year":"2017","unstructured":"Jain, N., Hwang, T., Franklin, J. M. & Kesselheim, A. S. Association of the priority review voucher with neglected tropical disease drug and vaccine development. JAMA. 318, 388\u2013389 (2017).","journal-title":"JAMA."},{"key":"56647_CR2","doi-asserted-by":"publisher","first-page":"e00048","DOI":"10.1128\/CMR.00048-18","volume":"31","author":"F Alves","year":"2018","unstructured":"Alves, F. et al. Recent development of visceral leishmaniasis treatments: successes, pitfalls, and perspectives. Clin. Microbiol. Rev. 31, e00048\u201318 (2018).","journal-title":"Clin. Microbiol. Rev."},{"key":"56647_CR3","doi-asserted-by":"publisher","DOI":"10.1186\/s40249-018-0444-1","volume":"7","author":"HB Weng","year":"2018","unstructured":"Weng, H. B., Chen, H. X. & Wang, M. W. Innovation in neglected tropical disease drug discovery and development. Infect. Dis. Poverty. 7, 67 (2018).","journal-title":"Infect. Dis. Poverty."},{"key":"56647_CR4","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1111\/j.1469-0691.2011.03630.x","volume":"17","author":"SL Croft","year":"2011","unstructured":"Croft, S. L. & Olliaro, P. Leishmaniasis chemotherapy-challenges and opportunities. Clin. Microbiol. Infect. 17, 1478\u20131483 (2011).","journal-title":"Clin. Microbiol. Infect."},{"key":"56647_CR5","doi-asserted-by":"publisher","first-page":"e0005480","DOI":"10.1371\/journal.pntd.0005480","volume":"11","author":"S Lamotte","year":"2017","unstructured":"Lamotte, S., Sp\u00e4th, G. F., Rachidi, N. & Prina, E. The enemy within: Targeting host\u2013parasite interaction for antileishmanial drug discovery. PLoS Negl. Trop. Dis. 11, e0005480 (2017).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"56647_CR6","doi-asserted-by":"publisher","first-page":"272","DOI":"10.3389\/fimmu.2014.00272","volume":"5","author":"BM Roatt","year":"2014","unstructured":"Roatt, B. M. et al. Immunotherapy and immunochemotherapy in visceral leishmaniasis: Promising treatments for this neglected disease. Front. Immunol. 5, 272 (2014).","journal-title":"Front. Immunol."},{"key":"56647_CR7","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1128\/CMR.18.2.293-305.2005","volume":"18","author":"M Olivier","year":"2005","unstructured":"Olivier, M., Gregory, D. J. & Forget, G. Subversion mechanisms by which Leishmania parasites can escape the host immune response: a signaling point of view. Clin. Microbiol. Rev. 18, 293\u2013305 (2005).","journal-title":"Clin. Microbiol. Rev."},{"key":"56647_CR8","first-page":"2751","volume":"17","author":"H Matsuoka","year":"1997","unstructured":"Matsuoka, H., Seo, Y., Wakasugp, H., Saito, T. & Tomoda, H. Lentinan potentiates immunity and prolongs the survival time of some patients. Anticancer Res. 17, 2751\u20132755 (1997).","journal-title":"Anticancer Res."},{"key":"56647_CR9","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1038\/nrd1865","volume":"4","author":"K Honey","year":"2005","unstructured":"Honey, K. \u03b2-Glucan conjugate provides protection. Nat. Rev. Drug Discov. 4, 814 (2005).","journal-title":"Nat. Rev. Drug Discov."},{"key":"56647_CR10","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.cellimm.2015.10.007","volume":"298","author":"VK Berner","year":"2015","unstructured":"Berner, V. K., duPre, S. A., Redelman, D. & Hunter, K. W. Microparticulate \u03b2-glucan vaccine conjugates phagocytized by dendritic cells activate both na\u00efve CD4 and CD8 T cells in vitro. Cell. Immunol. 298, 104\u2013114 (2015).","journal-title":"Cell. Immunol."},{"key":"56647_CR11","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1080\/09540105.2017.1324407","volume":"28","author":"B Vojtek","year":"2017","unstructured":"Vojtek, B., Moj\u017ei\u0161ov\u00e1, J., Smr\u010do, P. & Dr\u00e1\u017eovsk\u00e1, M. Effects of orally administered \u03b2\u20131,3\/1,6\u2013glucan on vaccination responses and immunological parameters in dogs. Food Agric. Immunol. 28, 993\u20131002 (2017).","journal-title":"Food Agric. Immunol."},{"key":"56647_CR12","doi-asserted-by":"publisher","first-page":"192","DOI":"10.3109\/00016489409128330","volume":"114","author":"Y Kimura","year":"1994","unstructured":"Kimura, Y., Tojima, H., Fukase, S. & Takeda, K. Clinical evaluation of sizofilan as assistant immunotherapy in treatment of head and neck cancer. Acta. Otolaryngol. 114, 192\u2013195 (1994).","journal-title":"Acta. Otolaryngol."},{"key":"56647_CR13","first-page":"1657","volume":"25","author":"H Tanabe","year":"1990","unstructured":"Tanabe, H., Imai, N. & Takechi, K. Studies on usefulness of postoperative adjuvant chemotherapy with lentinan in patients with gastrointestinal cancer. Nihon Gan Chiryo Gakkai Shi. 25, 1657\u20131667 (1990).","journal-title":"Nihon Gan Chiryo Gakkai Shi."},{"key":"56647_CR14","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.foodhyd.2010.02.001","volume":"25","author":"Y Zhang","year":"2011","unstructured":"Zhang, Y., Li, S., Wang, X., Zhang, L. & Cheung, P. C. K. Advances in lentinan: Isolation, structure, chain conformation and bioactivities. Food Hydrocoll. 25, 196\u2013206 (2011).","journal-title":"Food Hydrocoll."},{"key":"56647_CR15","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.3390\/molecules24071251","volume":"24","author":"V Vetvicka","year":"2019","unstructured":"Vetvicka, V., Vannucci, L., Sima, P. & Richter, J. Beta glucan: Supplement or drug? From laboratory to clinical trials. Molecules 24, 1251 (2019).","journal-title":"Molecules"},{"key":"56647_CR16","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1534\/genetics.112.144485","volume":"192","author":"P Orlean","year":"2012","unstructured":"Orlean, P. Architecture and biosynthesis of the Saccharomyces cerevisiae cell wall. Genetics 192, 775\u2013818 (2012).","journal-title":"Genetics"},{"key":"56647_CR17","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1517\/14712598.5.5.691","volume":"5","author":"J Yan","year":"2005","unstructured":"Yan, J., Allendorf, D. J. & Brandley, B. Yeast whole glucan particle (WGP) beta-glucan in conjunction with antitumour monoclonal antibodies to treat cancer. Expert Opin. Biol. Ther. 5, 691\u2013702 (2005).","journal-title":"Expert Opin. Biol. Ther."},{"key":"56647_CR18","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1021\/bc700329p","volume":"19","author":"ER Soto","year":"2008","unstructured":"Soto, E. R. & Ostroff, G. R. Characterization of multilayered nanoparticles encapsulated in yeast cell wall particles for DNA delivery. Bioconjug. Chem. 19, 840\u2013848 (2008).","journal-title":"Bioconjug. Chem."},{"key":"56647_CR19","doi-asserted-by":"crossref","unstructured":"Mirza, Z., Soto, E. R., Dikengil, F., Levitz, S. M. & Ostroff, G. R. Beta-glucan particles as vaccine adjuvant carriers in Vaccines for invasive fungal infections (eds. Kalkum, M. & Semis, M.) 143\u2013157 (Springer New York, 2017).","DOI":"10.1007\/978-1-4939-7104-6_11"},{"key":"56647_CR20","doi-asserted-by":"crossref","unstructured":"Paramera, E. I., Karathanos, V. T. & Konteles, S. J. Yeast cells and yeast-based materials for microencapsulation in Microencapsulation in the Food Industry. 267\u2013281 (Academic Press, 2014).","DOI":"10.1016\/B978-0-12-404568-2.00023-6"},{"key":"56647_CR21","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/ni1408","volume":"8","author":"PR Taylor","year":"2006","unstructured":"Taylor, P. R. et al. Dectin-1 is required for \u03b2-glucan recognition and control of fungal infection. Nat. Immunol. 8, 31 (2006).","journal-title":"Nat. Immunol."},{"key":"56647_CR22","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1111\/j.1600-065X.2009.00793.x","volume":"230","author":"HS Goodridge","year":"2009","unstructured":"Goodridge, H. S., Wolf, A. J. & Underhill, D. M. \u03b2\u2010glucan recognition by the innate immune system. Immunol. Rev. 230, 38\u201350 (2009).","journal-title":"Immunol. Rev."},{"key":"56647_CR23","doi-asserted-by":"publisher","first-page":"1119 LP","DOI":"10.1084\/jem.20021890","volume":"197","author":"GD Brown","year":"2003","unstructured":"Brown, G. D. et al. Dectin-1 Mediates the Biological Effects of \u03b2-Glucans. J. Exp. Med. 197, 1119 LP\u20131124 (2003).","journal-title":"J. Exp. Med."},{"key":"56647_CR24","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.clim.2007.05.002","volume":"124","author":"B Li","year":"2007","unstructured":"Li, B. et al. Yeast glucan particles activate murine resident macrophages to secrete proinflammatory cytokines via MyD88- and Syk kinase-dependent pathways. Clin. Immunol. 124, 170\u2013181 (2007).","journal-title":"Clin. Immunol."},{"key":"56647_CR25","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1016\/j.ijbiomac.2018.08.019","volume":"119","author":"H Volpato","year":"2018","unstructured":"Volpato, H. et al. In vitro anti-Leishmania activity of T6 synthetic compound encapsulated in yeast-derived \u03b2-(1,3)-d-glucan particles. Int. J. Biol. Macromol. 119, 1264\u20131275 (2018).","journal-title":"Int. J. Biol. Macromol."},{"key":"56647_CR26","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/1756-8722-2-25","volume":"2","author":"GCF Chan","year":"2009","unstructured":"Chan, G. C. F., Chan, W. K. & Sze, D. M. Y. The effects of beta-glucan on human immune and cancer cells. J. Hematol. Oncol. 2, 25 (2009).","journal-title":"J. Hematol. Oncol."},{"key":"56647_CR27","doi-asserted-by":"publisher","first-page":"208","DOI":"10.3389\/fcimb.2019.00208","volume":"9","author":"DB Scariot","year":"2019","unstructured":"Scariot, D. B. et al. Activity and cell-death pathway in leishmania infantum induced by sugiol: Vectorization using yeast cell wall particles obtained from Saccharomyces cerevisiae. Front. Cell. Infect. Microbiol. 9, 208 (2019).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"56647_CR28","first-page":"1009","volume":"29","author":"PST Veras","year":"1996","unstructured":"Veras, P. S. T. et al. Fusion of Leishmania amazonensis parasitophorous vacuoles with phagosomes containing zymosan particles: Cinemicrographic and ultrastructural observations. Brazilian. J. Med. Biol. Res. 29, 1009\u20131018 (1996).","journal-title":"J. Med. Biol. Res."},{"key":"56647_CR29","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1084\/jem.176.3.639","volume":"176","author":"PS Veras","year":"2004","unstructured":"Veras, P. S. Transfer of zymosan (yeast cell walls) to the parasitophorous vacuoles of macrophages infected with Leishmania amazonensis. J. Exp. Med. 176, 639\u2013646 (2004).","journal-title":"J. Exp. Med."},{"key":"56647_CR30","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1242\/jcs.107.11.3065","volume":"107","author":"PST Veras","year":"1994","unstructured":"Veras, P. S. T. et al. Fusion between large phagocytic vesicles: Targeting of yeast and other particulates to phagolysosomes that shelter the bacterium Coxiella burnetii or the protozoan Leishmania amazonensis in Chinese hamster ovary cells. J. Cell Sci. 107, 3065\u20133076 (1994).","journal-title":"J. Cell Sci."},{"key":"56647_CR31","doi-asserted-by":"publisher","first-page":"e0006052","DOI":"10.1371\/journal.pntd.0006052","volume":"11","author":"A Ponte-Sucre","year":"2017","unstructured":"Ponte-Sucre, A. et al. Drug resistance and treatment failure in leishmaniasis: A 21st century challenge. PLoS Negl. Trop. Dis. 11, e0006052 (2017).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"56647_CR32","doi-asserted-by":"publisher","first-page":"104967","DOI":"10.1016\/j.ejps.2019.104967","volume":"137","author":"BJ Boyd","year":"2019","unstructured":"Boyd, B. J. et al. Successful oral delivery of poorly water-soluble drugs both depends on the intraluminal behavior of drugs and of appropriate advanced drug delivery systems. Eur. J. Pharm. Sci. 137, 104967 (2019).","journal-title":"Eur. J. Pharm. Sci."},{"key":"56647_CR33","first-page":"13","volume":"9","author":"E Larra\u00f1eta","year":"2018","unstructured":"Larra\u00f1eta, E., Stewart, S., Ervine, M., Al-Kasasbeh, R. & Donnelly, R. F. Hydrogels for hydrophobic drug delivery. Classification, synthesis and applications. J. Funct. Biomater. 9, 13 (2018).","journal-title":"Classification, synthesis and applications. J. Funct. Biomater."},{"key":"56647_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms9791","volume":"6","author":"B Delalat","year":"2015","unstructured":"Delalat, B. et al. Targeted drug delivery using genetically engineered diatom biosilica. Nat. Commun. 6, 8791 (2015).","journal-title":"Nat. Commun."},{"key":"56647_CR35","doi-asserted-by":"publisher","first-page":"16071","DOI":"10.1038\/natrevmats.2016.71","volume":"1","author":"J Li","year":"2016","unstructured":"Li, J. & Mooney, D. J. Designing hydrogels for controlled drug delivery. Nat. Rev. Mater. 1, 16071 (2016).","journal-title":"Nat. Rev. Mater."},{"key":"56647_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-11533-1","volume":"7","author":"N Dimov","year":"2017","unstructured":"Dimov, N., Kastner, E., Hussain, M., Perrie, Y. & Szita, N. Formation and purification of tailored liposomes for drug delivery using a module-based micro continuous-flow system. Sci. Rep. 7, 12045 (2017).","journal-title":"Sci. Rep."},{"key":"56647_CR37","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.2217\/nnm.15.74","volume":"10","author":"R Bosetti","year":"2015","unstructured":"Bosetti, R. Cost\u2013effectiveness of nanomedicine: the path to a future successful and dominant market? Nanomedicine 10, 1851\u20131853 (2015).","journal-title":"Nanomedicine"},{"key":"56647_CR38","unstructured":"Organization, W. H. Visceral leishmaniasis: control strategies and epidemiological situation update in East Africa: report of a WHO bi-regional consultation Addis Ababa, Ethiopia, 9\u201311 March 2015 (World Health Organization, 2015)."},{"key":"56647_CR39","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1590\/0037-8682-0133-2017","volume":"50","author":"TSM de Assis","year":"2017","unstructured":"de Assis, T. S. M. et al. The direct costs of treating human visceral leishmaniasis in Brazil. Rev. Soc. Bras. Med. Trop. 50, 478\u2013482 (2017).","journal-title":"Rev. Soc. Bras. Med. Trop."},{"key":"56647_CR40","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1007\/s12639-014-0607-3","volume":"40","author":"P Bhattacharya","year":"2016","unstructured":"Bhattacharya, P. & Ali, N. Treatment of visceral leishmaniasis: anomalous pricing and distribution of AmBisome and emergence of an indigenous liposomal amphotericin B, fungisome. J. Parasit. Dis. 40, 1094\u20131095 (2016).","journal-title":"J. Parasit. Dis."},{"key":"56647_CR41","first-page":"340","volume":"12","author":"D Rousseau","year":"2001","unstructured":"Rousseau, D. et al. Sustained parasite burden in the spleen of Leishmania infantum-infected BALB\/c mice is accompanied by expression of MCP-1 transcripts and lack of protection against challenge. Eur. Cytokine Netw. 12, 340\u2013347 (2001).","journal-title":"Eur. Cytokine Netw."},{"key":"56647_CR42","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3389\/fcimb.2018.00394","volume":"8","author":"MdER Hermida","year":"2018","unstructured":"Hermida, Md. E. R. et al. Histological disorganization of spleen compartments and severe visceral leishmaniasis. Front. Cell Infect. Microbiol. 8, 394 (2018).","journal-title":"Front. Cell Infect. Microbiol."},{"key":"56647_CR43","doi-asserted-by":"publisher","first-page":"2870","DOI":"10.1021\/acs.molpharmaceut.8b00357","volume":"15","author":"T Ren","year":"2018","unstructured":"Ren, T. et al. Entrapping of nanoparticles in yeast cell wall microparticles for macrophage-targeted oral delivery of cabazitaxel. Mol. Pharm. 15, 2870\u20132882 (2018).","journal-title":"Mol. Pharm."},{"key":"56647_CR44","doi-asserted-by":"publisher","first-page":"639304","DOI":"10.1155\/2012\/639304","volume":"2012","author":"R Bankoti","year":"2012","unstructured":"Bankoti, R. & St\u00e4ger, S. Differential regulation of the immune response in the spleen and liver of mice infected with Leishmania donovani. J. Trop. Med. 2012, 639304 (2012).","journal-title":"J. Trop. Med."},{"key":"56647_CR45","doi-asserted-by":"publisher","first-page":"3709","DOI":"10.4049\/jimmunol.1300768","volume":"192","author":"PT Bunn","year":"2014","unstructured":"Bunn, P. T. et al. Tissue requirements for establishing long-term CD4+ t cell\u2013mediated immunity following Leishmania donovani infection. J. Immunol. 192, 3709\u20133718 (2014).","journal-title":"J. Immunol."},{"key":"56647_CR46","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1046\/j.1462-5822.2001.00150.x","volume":"3","author":"JM Blackwell","year":"2001","unstructured":"Blackwell, J. M. et al. SLC11A1 (formerly NRAMP1) and disease resistance. Cell. Microbiol. 3, 773\u2013784 (2001).","journal-title":"Cell. Microbiol."},{"key":"56647_CR47","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1084\/jem.182.3.655","volume":"182","author":"S Vidal","year":"1995","unstructured":"Vidal, S. The Ity\/Lsh\/Bcg locus: natural resistance to infection with intracellular parasites is abrogated by disruption of the Nramp1 gene. J. Exp. Med. 182, 655\u2013666 (1995).","journal-title":"J. Exp. Med."},{"key":"56647_CR48","doi-asserted-by":"publisher","first-page":"3618","DOI":"10.3390\/ijms20153618","volume":"20","author":"A Geller","year":"2019","unstructured":"Geller, A., Shrestha, R. & Yan, J. Yeast-derived \u03b2-glucan in cancer: novel uses of a traditional therapeutic. Int. J. Mol. Sci. 20, 3618 (2019).","journal-title":"Int. J. Mol. Sci."},{"key":"56647_CR49","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1080\/15476910802019045","volume":"5","author":"M Novak","year":"2008","unstructured":"Novak, M. & Vetvicka, V. \u03b2-glucans, history, and the present: immunomodulatory aspects and mechanisms of action. J. Immunotoxicol. 5, 47\u201357 (2008).","journal-title":"J. Immunotoxicol."},{"key":"56647_CR50","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1002\/eji.1830250310","volume":"25","author":"H Moll","year":"1995","unstructured":"Moll, H., Floh\u00e9, S. & R\u00f6llinghoff, M. Dendritic cells in Leishmania major-immune mice harbor persistent parasites and mediate an antigen\u2010specific T cell immune response. Eur. J. Immunol. 25, 693\u2013699 (1995).","journal-title":"Eur. J. Immunol."},{"key":"56647_CR51","first-page":"251","volume":"9","author":"AM Da-Cruz","year":"2002","unstructured":"Da-Cruz, A. M. et al. T-cell-mediated immune responses in patients with cutaneous or mucosal leishmaniasis: long-term evaluation after therapy. Clin. Diagn. Lab. Immunol. 9, 251\u2013256 (2002).","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"56647_CR52","doi-asserted-by":"crossref","first-page":"322","DOI":"10.4049\/jimmunol.151.1.322","volume":"151","author":"W Deng","year":"1993","unstructured":"Deng, W., Thiel, B., Tannenbaum, C. S., Hamilton, T. A. & Stuehr, D. J. Synergistic cooperation between T cell lymphokines for induction of the nitric oxide synthase gene in murine peritoneal macrophages. J. Immunol. 151, 322\u2013329 (1993).","journal-title":"J. Immunol."},{"key":"56647_CR53","first-page":"1520","volume":"6","author":"PD Fromm","year":"2015","unstructured":"Fromm, P. D., Kling, J. C., Remke, A., Bogdan, C. & Korner, H. Fatal leishmaniasis in the absence of TNF despite a strong Th1 response. Front. Microbiol. 6, 1520 (2015).","journal-title":"Front. Microbiol."},{"key":"56647_CR54","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1093\/infdis\/173.6.1515","volume":"173","author":"O Bacellar","year":"1996","unstructured":"Bacellar, O. et al. Interleukin-12 restores interferon-gamma production and cytotoxic responses in visceral leishmaniasis. J. Infect. Dis. 173, 1515\u20131518 (1996).","journal-title":"J. Infect. Dis."},{"key":"56647_CR55","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1128\/AAC.01014-09","volume":"54","author":"K Griewank","year":"2010","unstructured":"Griewank, K., Gazeau, C., Eichhorn, A. & von Stebut, E. Miltefosine efficiently eliminates Leishmania major amastigotes from infected murine dendritic cells without altering their immune functions. Antimicrob. Agents Chemother. 54, 652\u2013659 (2010).","journal-title":"Antimicrob. Agents Chemother."},{"key":"56647_CR56","doi-asserted-by":"publisher","first-page":"e26362","DOI":"10.1002\/pbc.26362","volume":"64","author":"N Parvaneh","year":"2017","unstructured":"Parvaneh, N. et al. Visceral leishmaniasis in two patients with IL-12p40 and IL-12R\u03b21 deficiencies. Pediatr. Blood Cancer. 64, e26362 (2017).","journal-title":"Pediatr. Blood Cancer."},{"key":"56647_CR57","doi-asserted-by":"publisher","first-page":"3235","DOI":"10.1128\/AAC.44.11.3235-3236.2000","volume":"44","author":"HW Murray","year":"2000","unstructured":"Murray, H. W. Suppression of posttreatment recurrence of experimental visceral leishmaniasis in T-cell-deficient mice by oral miltefosine. Antimicrob. Agents Chemother. 44, 3235\u20133236 (2000).","journal-title":"Antimicrob. Agents Chemother."},{"key":"56647_CR58","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.1128\/AAC.45.6.1872-1875.2001","volume":"45","author":"P Escobar","year":"2001","unstructured":"Escobar, P., Yardley, V. & Croft, S. L. Activities of hexadecylphosphocholine (miltefosine), ambisome, and sodium stibogluconate (pentostam) against Leishmania donovani in immunodeficient scid mice. Antimicrob. Agents Chemother. 45, 1872\u20131875 (2001).","journal-title":"Antimicrob. Agents Chemother."},{"key":"56647_CR59","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1086\/425359","volume":"39","author":"H Sindermann","year":"2004","unstructured":"Sindermann, H., Engel, K. R., Fischer, C. & Bommer, W. Oral miltefosine for leishmaniasis in immunocompromised patients: compassionate use in 39 patients with HIV infection. Clin. Infect. Dis. 39, 1520\u20131523 (2004).","journal-title":"Clin. Infect. Dis."},{"key":"56647_CR60","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1086\/315268","volume":"181","author":"HW Murray","year":"2000","unstructured":"Murray, H. W. & Delph\u2010Etienne, S. Visceral leishmanicidal activity of hexadecylphosphocholine (miltefosine) in mice deficient in t cells and activated macrophage microbicidal mechanisms. J. Infect. Dis. 181, 795\u2013799 (2000).","journal-title":"J. Infect. Dis."},{"key":"56647_CR61","doi-asserted-by":"publisher","first-page":"e0123009","DOI":"10.1371\/journal.pone.0123009","volume":"10","author":"AS Cavalcanti","year":"2015","unstructured":"Cavalcanti, A. S. et al. Parasite load induces progressive spleen architecture breakage and impairs cytokine mRNA expression in Leishmania infantum-naturally infected dogs. PLoS One 10, e0123009 (2015).","journal-title":"PLoS One"},{"key":"56647_CR62","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/s00281-015-0548-7","volume":"38","author":"PM Kaye","year":"2016","unstructured":"Kaye, P. M. & Beattie, L. Lessons from other diseases: granulomatous inflammation in leishmaniasis. Semin. Immunopathol. 38, 249\u2013260 (2016).","journal-title":"Semin. Immunopathol."},{"key":"56647_CR63","doi-asserted-by":"publisher","first-page":"5249","DOI":"10.1128\/JCM.42.11.5249-5255.2004","volume":"42","author":"C Mary","year":"2004","unstructured":"Mary, C., Faraut, F., Lascombe, L. & Dumon, H. Quantification of Leishmania infantum DNA by a Real-Time PCR Assay with High Sensitivity. J. Clin. Microbiol. 42, 5249\u20135255 (2004).","journal-title":"J. Clin. Microbiol."},{"key":"56647_CR64","doi-asserted-by":"publisher","first-page":"e88845","DOI":"10.1371\/journal.pone.0088845","volume":"9","author":"M Ceccarelli","year":"2014","unstructured":"Ceccarelli, M., Galluzzi, L., Migliazzo, A. & Magnani, M. Detection and characterization of Leishmania (Leishmania) and Leishmania (Viannia) by SYBR green-based real-time PCR and high resolution melt analysis targeting kinetoplast minicircle DNA. PLoS One 9, e88845 (2014).","journal-title":"PLoS One"},{"key":"56647_CR65","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1196\/annals.1307.018","volume":"1026","author":"F Vitale","year":"2004","unstructured":"Vitale, F. et al. TaqMan-based detection of Leishmania infantum DNA using canine samples. Ann. N. Y. Acad. Sci. 1026, 139\u2013143 (2004).","journal-title":"Ann. N. Y. Acad. Sci."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-56647-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-56647-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-56647-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,24]],"date-time":"2023-09-24T11:46:39Z","timestamp":1695555999000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-56647-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,27]]},"references-count":65,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["56647"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-56647-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,27]]},"assertion":[{"value":"25 February 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 December 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"20080"}}